News and blogs
385 results found.
Ed Davey reveals experience of blood cancer
Blood Cancer UK have welcomed the Lib Dem leaders cancer pledge after he revealed insight into blood cancer experience.
Myeloma drug approved for use
A new treatment for those with the blood cancer myeloma has been approved for use by NICE. It could benefit thousands.
Solomon's unexpected multiple myeloma diagnosis
After a shock diagnosis of multiple myeloma, Solomon talks about the importance of open and honest communication when facing blood cancer.
Ruxolitinib approved for treatment of polycythaemia vera in England and Wales
The drug, ruxolitinib, has been recommended for use by NICE to treat the blood cancer polycythaemia vera in those whose disease is resistant or intolerant to the treatments hydroxycarbamide/hydroxyurea.
The Scottish Medicines Consortium has approved two blood cancer treatments for use on the NHS in Scotland.
The Scottish Medicines Consortium has approved two blood cancer treatments for use on the NHS in Scotland.
Clinical trials can give people with blood cancer hope
Rachel contacted the Clinical Trials Support Service to find out whether she could potentially take part in a clinical trial and contribute to blood cancer research.
"The dark times can be overcome by anyone! - David's running epiphany
David Lauder has run the Great North Run 19 times to raise awareness of Blood Cancer.
Stephen Fry urges people to say blood cancer
Stephen Fry urges people with blood cancer to qualify that their individual condition is a type of blood cancer, to help raise crucial awareness.
Adults in the UK unable to name blood cancer symptom
Over half of the adults in the UK are unable to name a single blood cancer symptom, according to Blood Cancer UK's research.
Omaze raises £1.95 Million for Blood Cancer UK from Yorkshire Farmhouse!
The Omaze Million Pound House draw raised £1.95 million pounds for vital blood cancer research in just six weeks!
National Cancer Research Institute to close.
Blood Cancer UK's Sarah McDonald said it's sad that this long-standing, multi-partner collaboration is winding down.
Blood Cancer UK have renewed their partnership with RareCan
Blood Cancer UK have renewed their partnership with RareCan, a digital health company. This could give people an opportunity to help researchers.
A new dawn for clinical trials
A new dawn for clinical trials to get us to a place where no lives are lost to blood cancer
Remembering Lord Cadogan, honorary president of Blood Cancer UK
Remembering Lord Cadogan, honorary president of Blood Cancer UK
Lara raised £8,580 for Blood Cancer UK in memory of her father
Bradley lived with MPN - his daughter is now running the London Landmarks Half Marathon to support Blood Cancer UK.
How thinking differently about Pride is helping us do more to beat blood cancer
How we're supporting the LGBTQ+ community
Targeting tumor stroma could improve immunotherapy response in lymphoma
Blood Cancer UK researchers at King's College London have shown how specific cells known as ‘fibroblast cells’ in lymphoma tumours suppress the body’s immune cells and immunotherapy treatment.
Read Ed's story of being diagnosed with CLL
Ed shares his story of how our Clinical Trials Support Service helped support him through his diagnosis of CLL
My journey on a clinical trial
In this blog, James, who is living with chronic lymphocytic leukaemia, tells us about his journey with blood cancer, and discusses what research means to him.
Blood cancer drug ruxolitinib gives better outcomes than those on best-available existing medication
The drug, ruxolitinib, has been found to be better at treating the blood cancer - polycythaemia vera (PV) than the best currently available treatment.
